BSEAGM/EGM3d ago · 10 Aug 2026, 12:25 pm

We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable ....

Suraksha Diagnostic Ltd · 544293

✦ AI Summary

Suraksha Diagnostic Ltd has postponed its 21st Annual General Meeting (AGM) scheduled for September 2, 2026, due to unavoidable circumstances. The revised date, time, and venue will be announced later, in accordance with applicable laws and regulations.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suraksha Diagnostic Ltd - 544293 - Intimation Of Postponement Of The 21St Annual General Meeting Of The Company

Attachments (1)

📄

3cc7ee9a-6599-49d6-9bee-ff9e4f26b4bd.pdf

pdf

Download →
View document text
Date: 10 August 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Subject: Intimation of postponement of the 21st Annual General Meeting of the Company. Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our earlier intimation letter dated 21 May 2026, we wish to inform you that the 21st Annual General Meeting (“AGM”) of the Company, which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable circumstances. The revised date, time and venue for holding the 21st AGM will be decided in due course, accordance with the applicable provisions of the Companies Act, 2013 read with rules made thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the same shall be informed to the Stock Exchanges and shareholders accordingly. We request you to take the above on record. The Company regrets any inconvenience caused to the shareholders on account of the aforesaid postponement. Thanking you. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Encl.: as above Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750